Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with oc
Ductal carcinoma in situ: Value of sentinel lymph node biopsy
✍ Scribed by Rita Sakr; Emmanuel Barranger; Martine Antoine; Herve Prugnolle; Emile Daraï; Serge Uzan
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 92 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Sentinel lymph node biopsy is frequently associated with identification of micrometastatic tumor deposits. The clinical relevance of identifying micrometastases in breast cancer must be evaluated in the statistical context of the lymph node evaluation strategy and the likelihood of missing a metasta
BACKGROUND. Widespread use of mammography has increased the detection of ductal carcinoma in situ with microinvasion (DCISM) in pathology specimens. Currently there is disagreement regarding the incidence of axillary metastasis from DCISM. The controversy centers on whether complete lymphadenectomy